May 12, 2022
Video
Description: Before closing out his discussion on polycythemia vera management, Prithviraj Bose, MD, shares excitement for emerging therapeutics in this setting.
May 12, 2022
Video
Expert perspectives on long-term management of patients with polycythemia vera, with regard for the risk of developing secondary MF or AML.
May 12, 2022
Video
In discussing the role of ruxolitinib in HU-resistant or intolerant PV, expert Prithviraj Bose, MD, highlights data from the RESPONSE and RESPONSE-2 clinical trials.
May 12, 2022
Video
Considerations for therapy when patients with polycythemia vera experience hydroxyurea resistance or intolerance.
May 12, 2022
Video
A comprehensive review of the treatment armamentarium for polycythemia vera, as well as strategies to monitor patients on therapy in this setting.
May 12, 2022
Video
Expert Prithviraj Bose, MD, reviews standard practices in diagnosing and risk stratifying uncontrolled polycythemia vera in the context of a patient case.